ESR1 and breast cancer: The expression profiles of PKMYT1 were examined across PAM50 breast cancer subtypes using 5861 patients with breast cancer cohorts in bc‐GenExMiner 4.0, based on different clinical‐pathological indicators; estrogen receptors group and progesterone receptors groups were compared with the corresponding positive groups.